Home / Improving Care Coordination / OCCM Presentation Detail

[Abstract #104] An Optimal Care Coordination Model (OCCM) for Medicaid Patients With Lung Cancer: Finalization of the Model and Implications for Clinical Practice in the US

October 9, 2020
Presented at the 2020 ASCO Quality Care Symposium, October 9 to October 10, 2020.

Authors

Randall A. Oyer1; Christopher S. Lathan2,3; Matthew P. Smeltzer4; Amanda Kramar5; Leigh M. Boehmer5; Thomas M. Asfeldt6,7

1Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA, USA; 2Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center, Boston, MA, USA; 3Harvard Medical School, Boston, MA, USA; 4Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, TN, USA; 5Association of Community Cancer Centers, Rockville, MD, USA; 6Sanford USD Medical Center, Sioux Falls, SD, USA; 7Sanford Health Cancer Center, Worthington, MN, USA

Background

In 2016, the Association of Community Cancer Centers (ACCC) launched a 3-year initiative to design, test, and refine an Optimal Care Coordination Model (OCCM) for Medicaid patients with lung cancer in the United States (U.S.).

The aim was to help cancer programs identify and reduce the barriers experienced by Medicaid patients by strengthening lung cancer care delivery systems.

An environmental scan identified broad barriers to optimal care delivery for Medicaid patients diagnosed with lung cancer.

Here, we present the final Model, including the 12 assessment areas, and its nationwide dissemination through ACCC’s extensive network of U.S. cancer program members.




Our Supporter

BMS-Foundation-300x110 regeneron-200x80 Support provided by Bristol Myers Squibb Foundation and Regeneron